What died in conference
Texas opened its 2025 session with what defense interests billed as the most serious nuclear-verdict reform in a decade. Senate Bill 30, carried by Schwertner, and its House companion HB 4806, carried by Bonnen, would have capped non-economic damages in many injury cases, required all twelve jurors to agree on a non-economic award instead of the current ten, and tied future medical-cost recovery to a state claims database keyed to a multiple of Medicare rates.
Neither became law. The package cleared a chamber and then stalled in conference committee in late April, with the two sides unable to reconcile the House and Senate versions on the unanimous-jury rule and the medical-cost cap. The legislature meets every two years. The earliest a serious reform can return is 2027, which leaves roughly twenty months of the pre-reform trial environment running from the day the bills failed.
What the failure means on the ground
Two things follow from a reform that big falling short. First, the verdict pattern the bills targeted keeps running. Texas produced a string of eight- and nine-figure jury awards in trucking, premises, and product cases through 2024 and into 2025, and the numbers since the session ended have not visibly bent. Second, defense firms cannot build a hiring plan around a law that may or may not arrive in two years. The capacity to try the next major case has to be on the bench in 2026, not on a wish list for after the 2027 vote.
In Texas we are seeing defense firms hire at higher class years than they did in 2023 and stretch above their historical bands to lock in proven trial experience, because the capacity to try the next case cannot wait for a statute that may never come.
Where the hiring is going
The demand sits in the practices that draw the biggest verdicts. Trucking and commercial transportation defense, premises liability for retail and hospitality, construction defect on large projects, and product liability all show active senior-level openings across Houston, Dallas, Austin, and San Antonio in early 2026. The candidates these insurance defense firms chase share a profile. First-chair trial experience that is real. A willingness to try cases that big-firm peers would settle. And standing with the carriers who write the checks.
A second lane has opened that barely existed two years ago. Some of the firms staffing the largest Texas trials will now hire from plaintiff practices or from out-of-state commercial litigation, as long as the candidate can actually stand up in front of a jury. Trial credit has started to outweigh pedigree.
The talent the failed bill made more valuable
A reform that nearly passed and then did not does something specific to the price of senior trial talent. With no statutory shield coming, the lawyer who can try a hard case in front of a Texas jury becomes the firm's main tool for managing exposure. That lawyer's leverage rose in 2025 and has not come back down.
When a Texas firm wants a senior trial lateral right now, the concession we tell them to be ready to make is on origination credit and partnership timing, not on base alone. The lawyers who can actually try these cases know what they are worth, and the firms that win them compete on the whole package.
What 2027 changes, and what it does not
The package will almost certainly return in 2027, and the version that comes back will probably be softer, most likely keeping the medical-cost reform and dropping the unanimous-jury rule that drew the hardest opposition this round. If a compromise like that passes, exposure on certain cases drops and the hiring math shifts with it. If it fails again, the current pattern simply runs another two years.
Our read is that firms should hire through the 2027 session as if reform is not coming, and treat any relief that does pass as upside rather than the plan. Waiting for certainty buys nothing here. The talent stays scarce either way, and come 2027 the firms that waited will be chasing it with no head start.